Literature DB >> 1993843

Generation of monoclonal antibodies to murine IL-1 beta and demonstration of IL-1 in vivo.

K A Hogquist1, M A Nett, K C Sheehan, K D Pendleton, R D Schreiber, D D Chaplin.   

Abstract

The role of murine IL-1 beta in vitro and in vivo has not been defined. We describe here the production of neutralizing and immunoprecipitating mAb and polyclonal antibodies specific for murine IL-1 beta and their application to a characterization of the murine IL-1 beta protein. Immunization of either hamsters or rabbits with the recombinant mature form of murine IL-1 beta emulsified in CFA elicited antisera and hamster mAb that only recognized denatured IL-1 beta. In contrast, immunization with rIL-1 beta adsorbed to alum resulted in the generation of neutralizing and immunoprecipitating rabbit and hamster antisera and hamster mAb. All of the mAb recognize both the pro-form of IL-1 beta and the mature bioactive form produced by cultures of murine peritoneal macrophages. Using these antibodies, we demonstrate that approximately half of the IL-1 activity present in supernatants of LPS-treated cultured mouse macrophages is composed of IL-1 beta. Additionally, IL-1 beta as well as IL-1 alpha can be detected in the plasma of LPS-treated mice. These studies, therefore, demonstrate the production of IL-1 beta both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993843

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Interleukin-1 and host control of pulmonary histoplasmosis.

Authors:  George S Deepe; Michael McGuinness
Journal:  J Infect Dis       Date:  2006-08-10       Impact factor: 5.226

2.  Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-γ receptor subunit 1 (IFNGR1).

Authors:  Sang Hun Lee; Javier A Carrero; Ravindra Uppaluri; J Michael White; Jessica M Archambault; Koon Siew Lai; Szeman Ruby Chan; Kathleen C F Sheehan; Emil R Unanue; Robert D Schreiber
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

3.  Interleukin 8 and mast cell-generated tumor necrosis factor-alpha in neutrophil recruitment.

Authors:  Y Zhang; B F Ramos; B Jakschik; M P Baganoff; C L Deppeler; D M Meyer; D L Widomski; D J Fretland; M A Bolanowski
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

4.  Interleukin 1 is processed and released during apoptosis.

Authors:  K A Hogquist; M A Nett; E R Unanue; D D Chaplin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

5.  Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice.

Authors:  L G Guidotti; K Ando; M V Hobbs; T Ishikawa; L Runkel; R D Schreiber; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

6.  A mechanism for the inhibition of fever by a virus.

Authors:  A Alcamí; G L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Interleukin-1 (IL-1) production in a mouse tissue chamber model of inflammation. I. Development and initial characterisation of the model.

Authors:  J Dawson; C Rordorf-Adam; T Geiger; H Towbin; S Kunz; H Nguyen; O Zingel; D Chaplin; K Vosbeck
Journal:  Agents Actions       Date:  1993-03

8.  Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.

Authors:  C S Tripp; S F Wolf; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Binding of cytokines to pharmaceutically prepared human immunoglobulin.

Authors:  M Svenson; M B Hansen; K Bendtzen
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice.

Authors:  H W Rogers; K C Sheehan; L M Brunt; S K Dower; E R Unanue; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.